Cita APA

Cantin, G., Cortelezzi, A., Knauf, W., Tiab, M., Turgut, M., & Bosch, F. (2019). Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: A subgroup analysis of the GREEN study.

Citación estilo Chicago

Cantin, Guy, Agostino Cortelezzi, Wolfgang Knauf, Mourad Tiab, Mehmet Turgut, y Francesc Bosch. Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated, Fit Patients With Chronic Lymphocytic Leukemia: A Subgroup Analysis of the GREEN Study. 2019.

Cita MLA

Cantin, Guy, et al. Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated, Fit Patients With Chronic Lymphocytic Leukemia: A Subgroup Analysis of the GREEN Study. 2019.